According to FibroGen's latest financial reports the company's current EPS (TTM) is -2,99 โฌ. In 2022 the company made an earnings per share (EPS) of -2,77 โฌ a decrease over its 2021 EPS that were of -2,77 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -3,22 โฌ | 16.19% |
2022 | -2,77 โฌ | -0% |
2021 | -2,77 โฌ | 48.11% |
2020 | -1,87 โฌ | 140.91% |
2019 | -0,78 โฌ | -14.56% |
2018 | -0,91 โฌ | -32.68% |
2017 | -1,35 โฌ | 64.52% |
2016 | -0,82 โฌ | -34.51% |
2015 | -1,25 โฌ | -6.98% |
2014 | -1,35 โฌ |